Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trials to Evaluate the Efficacy and Safety of Runzao Zhiyang Capsule in Treating Chronic Eczema

NCT02601222 is registered in ClinicalTrials.gov with Guizhou Tongjitang Pharmaceutical Co.,Ltd as lead sponsor.

NCT NCT02601222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trials to Evaluate the Efficacy and Safety of Runzao Zhiyang Capsule in Treating Chronic Eczema
Lead sponsor
Guizhou Tongjitang Pharmaceutical Co.,Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2016
Completion date
February 28, 2017
Enrollment
240 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic eczema